Power Of Genomics To Tackle The Obesity Crisis

Power Of Genomics The Obesity Crisis. The etiology, clinical picture, and complications of obesity vary significantly from patient to patient. Making prevention and treatment of the disease difficult. In the current healthcare system, obesity treatment follows an algorithm that begins with lifestyle changes and then progresses to medication. Furthermore, endoscopic devices, and bariatric surgery, depending on the patient’s response. The increasing prevalence of obesity and the lack of established and validated therapeutic options warrant the search for alternative therapeutic strategies that complement current paradigms. Ideally, new methods should be individually customize to increase efficacy and tolerability in the form of precision medicine.

Tipping The Scales: The Power Of Genomics To Tackle The Obesity Crisis

Obesity has almost tripled worldwide since 1975. To address this problem, governments worldwide have enacted laws to reduce obesity, including cheap fast food, large portions, and a sedentary lifestyle. However, new research from BGI Group and the Chinese Academy of Sciences suggests that the answer to this growing crisis may lie in genomic innovation. Adults are also affected by this crisis. Scientists predict that by 2030 nearly one in two adults will be obese. Moreover, almost one in four will be severely obese.

What Or Who Is To Blame Power Of Genomics the Obesity Crisis

As Kimberley Neve, research associate at the Food Policy Center, explains. “Even those trying to (lose weight) are bother by unhealthy food options that are everywhere. Easy to find, cheap to buy, quick and tempting.” Around this problem To address this, governments worldwide have enacted a series of new research published in Nature by BGI Group.

The Chinese Academy of Sciences and research teams from China, Singapore, Germany, Italy, the UK, Sweden, and Spain have found that processed foods are improving, reducing and physically active. Half is Fighting, and genomic innovation is leading the way against obesity.

Study Implications Are Significant Power Of Genomics the Obesity Crisis

From Alzheimer’s and Parkinson’s diseases to cancer and Covid-19, the single-cell technology used by the BGI group and the Chinese Academy of Sciences. Offers unusual insight into the body’s inner workings for valuable clues to treating disease. Just as improvements in geographic maps, from 15th-century parchment maps to Google Maps software. Then, have led to a better understanding of Earth’s geography, cell maps created with single-cell technology could open the door to experiencing and treating overt diseases. While obesity treatment has focused on lifestyle changes through diet and exercise for decades, a study by BGI Group suggests genomics will play a key role in solving this growing crisis.

What Is Precision Medicine Power Of Genomics the Obesity Crisis

Precision Medicine is based on the principle that most current therapeutic and preventive approaches. Then, a given disease are based on the average patient and do not consider human variability. In contrast to this single tactic, precision medicine considers individual variations in genetics, metabolites, the gut microbiome, and environmental factors. All of which can influence them, to predict which treatment and disease prevention strategy will work best in which population5. Obesity is classified according to the degree of overweight, the distribution of fatty tissue, and its complications. Approaches focusing on high-resolution.

Furthermore, biotechnological data mining has the potential to identify unbiased subgroups to generate novel pathophysiological hypotheses.

Genomics Helps Tackle The Obesity Epidemic

Our work on obesity includes a critical review of the research into the genetics of obesity. The public health benefit, and the clinical utility of whole genome sequencing for obese patients. In the resulting report, The Genomics of Obesity, published in 2013. We discuss if and how genomics could be integrated into existing NHS care pathways and set out our findings and recommendations for policymakers. Current government policy focuses on the environmental causes of obesity. We wanted to know whether there were public health benefits to a policy change incorporating genomics.

Genomics, Type 2 Diabetes, and Obesity

Our work on obesity includes a critical review of the research into the genetics of obesity, the public health benefit. The clinical utility of whole genome sequencing for obese patients. In the resulting report, The Genomics of Obesity, issue in 2013. We discuss if and how genomics could be integrated into existing NHS care pathways and set out our findings and recommendations for policymakers. Current government policy focuses on the environmental causes of obesity. Finally, we wanted to know whether there were public health benefits to a policy change incorporating genomics.

Genomic Knowledge Is The Power In The Fight Against Obesity

Health professionals who speak to obese mothers about genomic and behavioral risk factors can induce guilt in those mothers for passing the disease on to their children. Dr However, Persky believes that discussions between doctors and patients about genomics – both about weight loss and other diseases – are becoming more frequent. However, researchers wanted to see if the doctor’s working style might conflict with the statement that genomic factors play a crucial role in weight control.

Conclusion

While obesity treatment has focused on lifestyle changes through diet and exercise for decades. A study by BGI Group suggests genomics will play a key role in solving this growing crisis. In contrast to this single tactic, precision medicine considers individual variations in genetics, metabolites, the gut microbiome, and environmental factors. Finally, all of which can influence them, to predict which treatment and disease prevention strategy will work best in which population.

HELPFULL RESOURCES : Severely Overweight Here Are Your Best Options